Byrna (NASDAQ:BYRN) Misses Q2 CY2026 Sales Expectations, Stock Drops 24.1%

Byrna (NASDAQ:BYRN) reported Q2 CY2026 revenue of $16.39 million, down 42.5% year on year, missing Wall Street expectations. GAAP EPS was -$0.44, also below consensus. Management said results did not match expected performance. The stock fell about 24% to $4.49 after the release.

Original reporting
Published Jul 9, 2026, 1:30 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 9, 2026, 2:27 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Byrna (NASDAQ:BYRN) Misses Q2 CY2026 Sales Expectations, Stock Drops 24.1% — source image
Decision brief

The 30-second read

$BYRNBearishMed
01

Why it matters

The key new information is the Q2 CY2026 revenue and EPS miss versus Wall Street expectations, alongside a large year-on-year revenue contraction and a sharp immediate stock drop.

02

Market read

Traders can reassess near-term growth and profitability expectations after the earnings miss and the magnitude of the stock reaction.

03

What to watch

The text highlights operating margin deterioration this quarter (-78.4%) but does not break out one-time items, channel inventory effects, or order timing that could distort the quarter.

Relevance 8/10Novelty 7/10Timing: after-hours/next-session reaction to Q2 CY2026 results and guidance expectations

Background

Byrna is a non-lethal weapons company; the article frames its recent performance versus longer-term growth trends.

Company-level read

Ticker impact

$BYRNBearishHigh confidence
Context

Byrna reported Q2 CY2026 revenue down 42.5% to $16.39M and EPS of -$0.44, missing consensus and sending shares down ~24%.

Expected impact

Bearish bias for the next days to weeks as traders reprice growth and margin trajectory after the miss.

Evidence & confidence

The article provides specific Q2 revenue and EPS figures versus expectations, plus the immediate post-results stock drop, indicating a fresh repricing event.

Market effects

Weak demand signals for non-lethal weapons suppliers could weigh on sentiment for similarly positioned defense-adjacent small caps.

No specific regional spillover described beyond US small-cap sentiment.

No global macro or international demand drivers cited.

Counterpoint

Despite the revenue decline, the article notes EBITDA beat and operating leverage improvements, which could support a stabilization trade if margins hold.

Key entities

  • Byrna

    Reported Q2 CY2026 revenue of $16.39M (down 42.5% YoY) and EPS of -$0.44, missing expectations.

  • Conn Davis

    CEO who said Q2 results did not reflect the performance level management believes Byrna can deliver.

Related articles

$BYRNLow

Why Byrna (BYRN) Shares Are Sliding Today

Byrna (NASDAQ: BYRN) shares fell about 4% after the company appointed James White as Senior VP of Retail and Channel Growth, overseeing retail and e-commerce channels and reporting to CEO Conn Davis. The move follows a sales and marketing realignment. The stock traded near its 52-week low around $3.29, after prior Q2 2026 results missed expectations.

$BYRNMedAI 8/10

Byrna Technologies Stock Slips 26% After Reporting Loss In Q2

Byrna Technologies Inc. (BYRN) shares fell about 26% to $4.37 on the Nasdaq after the company reported a Q2 loss of $10.1 million versus $2.4 million a year earlier. Net revenue dropped to $16.4 million from $28.5 million, citing lower e-commerce sales and slower dealer and chain reorders.

$BYRNMedAI 9/10

Byrna Technologies Q2 Earnings Call Highlights

Byrna Technologies (NASDAQ: BYRN) reported Q2 gross profit of $1.8M (11% of net revenue) versus $17.6M (62%) a year earlier, including $3.6M inventory write-down, $3.5M equipment impairment, and $2.3M inventory reserve. Net loss was $10.1M. Management cited weaker e-commerce conversion and expects no FY2026 revenue growth. Byrna agreed to acquire HERO Defense Systems for $1.25M plus royalties.

$BYRNMedAI 8/10

Why Byrna (BYRN) Stock Is Falling Today

Byrna (NASDAQ: BYRN) shares fell 25.8% after the company reported Q2 2026 results that missed expectations. Revenue dropped 42.5% year over year to $16.39 million versus $22.22 million estimates. Byrna posted a GAAP loss of $0.44 per share versus a $0.11 loss consensus and a $0.10 profit a year earlier.

$BYRNMed

Byrna Technologies Inc. (BYRN): Results of Operations and Financial Condition

Byrna Technologies Inc. (BYRN) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 ex_985847.htm EXHIBIT 99.1 ex_985847.htm Exhibit 99.1 Byrna Technologies Reports Fiscal Second Quarter 2026 Results ANDOVER, Mass., July 9, 2026 - Byrna Technologies Inc. ( “ Byrna ” or the “ Company ” ) (Nasdaq: BYRN) , a personal defense technology company specializin